Valuable organization created to support research and raise awareness and advocacy for SYNGAP1 patients and families opens fourth facility in the Southeast U.S.

Bridge the Gap – SYNGAP Education and Research Foundation is excited to announce the opening of its fourth U.S. Southeast SYNGAP1 Center of Excellence. 

Bridge the Gap — SYNGAP Education and Research Foundation is the world’s leading not-for-profit SYNGAP1 patient advocacy center developed to gather critical research and establish collaborative partnerships to raise global awareness about SYNGAP1.  

SYNGAP1 – related non-syndromic intellectual disability (NSID) in humans — was first reported in 2009. It is considered one of the top single gene mutations being researched worldwide and linked to autism. In addition, a mutation in SYNGAP1 results in intellectual disabilities ranging from mild to severe. Epilepsy and a multitude of other comorbidities may occur from as attention deficit disorder to impulsivity and/or mood disorders. 

According to current research, approximately 85 percent of SYNGAP1 patients have some type of epilepsy.  It also plays an important role in brain plasticity and may represent one of the most common causes of ID worldwide.  The use of genomic sequencing has dramatically increased the capacity of physicians to identify these mutations.

Read the rest of the article here: https://www.prdistribution.com/news/valuable-organization-created-to-support-research-and-raise-awareness-and-advocacy-for-syngap1-patients-and-families-opens-fourth-facility-in-the-southeast-us/5675110

Previous
Previous

Reactions from the 2020 SYNGAP1 Scientific Conference

Next
Next

When your son has the sixth SYNGAP-1 diagnosis in the world- Ft. Monica Weldon from Bridge the Gap